PubMed Conditions Bacteria Progression

Condition: Percent Association πŸ“Ή Video Explanation

See Conditions leading to

See All Conditions

Caution:This is based on bacteria in common. Some conditions have short lists due to few studies. DNA is also a significant factor for developing or not developing a condition.

Related Condition Name Overlab Percentage
Acne 63 %
ADHD 55 %
Allergies 41 %
Alzheimer`s disease 50 %
Amyotrophic lateral sclerosis (ALS) Motor Neuron 49 %
Ankylosing spondylitis 53 %
Anorexia Nervosa 83 %
Asthma 42 %
Atherosclerosis 38 %
Autism 49 %
Barrett esophagus cancer 44 %
Bipolar Disorder 36 %
Brain Trauma 61 %
Carcinoma 72 %
Celiac Disease 46 %
Cerebral Palsy 88 %
Chronic Fatigue Syndrome 38 %
Chronic Kidney Disease 69 %
Chronic Obstructive Pulmonary Disease (COPD) 53 %
Chronic Urticaria (Hives) 57 %
Coagulation / Micro clot triggering bacteria 32 %
Colorectal Cancer 38 %
Constipation 75 %
Coronary artery disease 44 %
COVID-19 42 %
Crohn`s Disease 55 %
cystic fibrosis 50 %
deep vein thrombosis 40 %
Depression 38 %
Dermatomyositis 78 %
Eczema 58 %
Endometriosis 49 %
Eosinophilic Esophagitis 53 %
Epilepsy 63 %
Fibromyalgia 34 %
Functional constipation / chronic idiopathic constipation 41 %
gallstone disease (gsd) 65 %
Gastroesophageal reflux disease (Gerd) including Barrett`s esophagus 57 %
Generalized anxiety disorder 38 %
Gout 43 %
Graves` disease 68 %
Hashimoto`s thyroiditis 48 %
Hidradenitis Suppurativa 31 %
hypercholesterolemia (High Cholesterol) 31 %
Hyperlipidemia (High Blood Fats) 54 %
hypersomnia 50 %
hypertension (High Blood Pressure 40 %
IgA nephropathy (IgAN) 41 %
Inflammatory Bowel Disease 47 %
Insomnia 54 %
Irritable Bowel Syndrome 50 %
Juvenile idiopathic arthritis 32 %
Liver Cirrhosis 63 %
Lung Cancer 68 %
ME/CFS with IBS 44 %
ME/CFS without IBS 40 %
Metabolic Syndrome 39 %
Mood Disorders 35 %
Multiple Sclerosis 39 %
Multiple system atrophy (MSA) 35 %
Neuropathy (all types) 60 %
neuropsychiatric disorders (PANDAS, PANS) 60 %
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 44 %
Obesity 34 %
obsessive-compulsive disorder 39 %
Osteoarthritis 73 %
Osteoporosis 61 %
Parkinson`s Disease 47 %
Postural orthostatic tachycardia syndrome 50 %
Premenstrual dysphoric disorder 80 %
Psoriasis 51 %
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 45 %
Rosacea 48 %
Schizophrenia 48 %
Sjögren syndrome 54 %
Sleep Apnea 63 %
Small Intestinal Bacterial Overgrowth (SIBO) 33 %
Stress / posttraumatic stress disorder 47 %
Systemic Lupus Erythematosus 63 %
Type 1 Diabetes 49 %
Type 2 Diabetes 48 %
Ulcerative colitis 59 %
Unhealthy Ageing 68 %

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.